# Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/statement-of-identity-and-strength-content-and-format-of-labeling-for-human-nonprescription-drug-products/eedd66d7-1c8a-4071-8ce6-a53c3f8790a3

> FDA guidance document: Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products. Issue date: September 08, 2022. Get complete insights and analysis.

---

## Details

- Title: Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-09-08
- Comment Close Date: 2022-11-08
- Last Changed: 2022-09-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-1837">FDA-2022-D-1837</a>

## Related Documents

- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)
- [Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs](https://www.globalkeysolutions.net/guidances/guidance-document/content-and-format-of-composition-statement-and-corresponding-statement-of-ingredients-in-labeling-in-ndas-and-andas/a430f093-c9f8-4001-aef8-771d98ffdbf0)
- [Innovative Approaches for Nonprescription Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/innovative-approaches-for-nonprescription-drug-products/212b0dcc-7c8f-44f5-8fd2-1af604a50f9a)